TB or not TB? – ViroLIEgy
Where is the “infection?” One of the reasons I like to engage with people who challenge me about pathogenic “viruses” and bacteria is that I always come away with something new from the…| ViroLIEgy
Freya Cook explores the development of a more effective tuberculosis vaccine and the current challenges researchers face. The post Why don’t we have a good tuberculosis vaccine? appeared first on The Oxford Scientist.| The Oxford Scientist
Where is the “infection?” One of the reasons I like to engage with people who challenge me about pathogenic “viruses” and bacteria is that I always come away with something new from the…| ViroLIEgy
2min read Apparently we need to mass vaccinate for "latent" diseases| PANDA
On World TB Day 2025, we look at the most recent data, which showed a rise of 13% in reported numbers of cases in England between 2023 and 2024.| ukhsa.blog.gov.uk
Tuberculosis (TB) is a big killer in many countries of the world, particularly in those with low and middle income. Next-generation sequencing has been key in improving our understanding of drug resistance acquisition and of transmission of Mycobacterium tuberculosis. Yet, the need for expertise guiding NGS implementation in laboratories and the lack of bioinformatic expertise, are main obstacles hindering the implementation of NGS into TB programs.| Galaxy Training Network
